Home » Drug Information » FDA Approved Drugs » 1998
The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.
Company:
Watson Pharmaceuticals
Approval Status:
Approved January 1998
Specific Treatments:
anticonvulsant
Therapeutic Areas
NeurologyFamily MedicineGenetic Disease
Seizure Disorders
Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.
Copyright © 1995-2018 CenterWatch.
Clinical Trial Portals Absolutely, Positively Essential for Small, Mid-Size Biotech Firms A WCG | CenterWatch FREE Webinar Friday, April 27, 2018 • 1:30 p.m. - 2:30 p.m. EDT
A WCG | CenterWatch FREE Webinar
Friday, April 27, 2018 • 1:30 p.m. - 2:30 p.m. EDT
REGISTER NOW